Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nichi-Iko Of Japan Invests ¥7.3 Billion To Build New Production Facility

This article was originally published in PharmAsia News

Executive Summary

Toyama-based generic drug maker Nichi-Iko Pharmaceutical announced it will build a new production facility in Katsukawa, Toyama prefecture. Chiyoda TechnoAce, a subsidiary of Yokohama-based Chiyoda Corp has been awarded the ¥7.3 billion construction contract. Construction starts this September and will be completed by October 2009. Actual production is expected to start in December 2009. The Japanese generics market has been growing and generics makers are speeding up facility investment and the integration of production and research facilities to boost efficiency. (Click here for more - Japanese language
UsernamePublicRestriction

Register

SC068605

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel